Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot study- Phase II clinical study of TY-0305in symptomatic patients with hypertrophic obstructive cardiomyopat ...
Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot study- Phase II clinical study of TY-0305in symptomatic patients with hypertrophic obstructive cardiomyopat ...
Intervention name : TY-0305 INN of the intervention : Cibenzoline Dosage And administration of the intervention : Two tablets orally of TY-0305 50mg twice or three times daily Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Intervention name : TY-0305 INN of the intervention : Cibenzoline Dosage And administration of the int ...